During this era, the dominant paradigm linked disease to the loss of specific lysosomal enzymes, reframing lysosomal storage diseases as enzymopathies rather than merely storage disorders. Biochemical characterization and substrate accumulation were central, and enzymatic assays became practical tools for diagnosis, even with small blood samples. The work of integrating laboratory enzymology with clinical screening established enzyme-based diagnostics as foundational to LSD research.